Eris Lifesciences Limited has informed the Exchange regarding Cessation of Rajeev Dalal as Non- Executive Independent Director of the company w.e.f. December 18, 2025.
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences has informed the stock exchange that Rajeev Dalal has ceased to be a Non-Executive Independent Director of the company with effect from December 18, 2025. The company has not disclosed the specific reason for his departure in this filing — it could relate to completion of his term, personal reasons, or other factors. No other directors are mentioned as stepping down in this announcement. No replacement appointment has been announced alongside this cessation.
This is a single Independent Director exit with no disclosed governance concern, so it is unlikely to materially affect the stock price. Shareholders may want to watch for an announcement regarding a replacement independent director, as board composition changes are worth tracking for governance continuity.